Biliary Tract Cancer - 80 Studies Found
| Not yet recruiting |
: Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers :
|
| Completed |
: Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers :
: 2008-02-14 :
|
| Completed |
: A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers : Cancer : 2013-09-12 :
|
| Completed |
: Cetuximab + Gemox in Biliary Tract Cancer :
: 2010-10-04 : Drug: Cetuximab + Gemcitabine + Oxaliplatin Cetuximab 500mg/m2, iv every two weeks Gemcitabine 1000mg/m2 |
| Completed |
: Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer :
: |
| Completed |
: Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study : Time to Progression : 2008-09-03 : Drug: gemcitabine + cetuximab gemcitabine 1g/m² 3weeks/4 cetuximab 400 mg/m² the first week, t |
| Recruiting |
: Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer : Digestive Cancer : 2015-03-02 :
|
| Active, not recruiting |
: Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control :
: 2013-12-02 :
|
| Completed |
: Covered Versus Uncovered SEMS for Palliation of Malignant Biliary Strictures. : Biliary Cancer : 2016-10-07 :
|
| Recruiting |
: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours :
|